Drugs sold outside regulated channels are showing up in places that look clinical. According to MedCity News, patients are obtaining substances through social media, medical spas, and telehealth platforms — and these buyers are not the same as people who seek out traditional illicit markets.
Because the transaction happens through a familiar or professional-looking channel, patients often believe the product has been clinically validated. The article argues that this belief sets them apart from people who knowingly buy through traditional illicit channels, and it may shape how they understand the risks.
The distinction matters for clinicians. A patient may not identify their purchase as "street drugs" at all, so asking about how and where medications were obtained could help surface sources that might otherwise go unnoticed.